Spyre Therapeutics Inc <SYRE.O>: Baird Cuts Target Price to $116 From $120
SYRE•Related News
Qantas upbeat on revenue, brings forward A380 exit as profit falls
BA•
Faraday Future targets robot factory launch by year-end under “Built in USA” expansion program
FFAI•
CrowdStrike <CRWD.O>: Scotiabank raises target price to $250 from $227
CRWD•
The J. M. Smucker Company <SJM.N>: BTIG raises target price to $150 from $130
SJM•
The J. M. Smucker Company <SJM.N>: TD Cowen raises target price to $136 from $123
SJM•